is semaglutide still on shortage list As of February 21, 2025, the FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A US judge upholds FDA's removal

This dose sits in a range that many practitioners consider the sweet spot, strong enough for significant results but lower than the doses most associated with severe GI effects

Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP1-RAs) are an effective class of drugs for the treatment of type 2 diabetes mellitus (T2D), with well-defined safety and tolerability profiles

When to Seek Medical Guidance Mild bloating or occasional constipation in the first month of semaglutide is normal and typically resolves without intervention

Excessive calorie restriction, inadequate protein intake, or improper dosing can worsen fatigue, slow metabolism, and intensify thyroid-related symptoms

Continued Monitoring and Supplement Options Ongoing monitoring is key during dose titration